ENO2 and lung carcinoma: Therefore, we highlight that lung‐cancer‐related STMs (NSE, CEA, CA125, CA153, CYFRA21‐1, SCC) could be potential predictors of resistance and prognosis of lung cancer treated with targeted therapy.